Strata Skin Sciences Net Long-Term Debt 2010-2025 | SSKN

Strata Skin Sciences net long-term debt from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
Strata Skin Sciences Annual Net Long-Term Debt
(Millions of US $)
2024 $N/A
2023 $7
2022 $N/A
2021 $0
2020 $3
2019 $0
2018 $-3
2017 $-1
2016 $2
2015 $43
2014 $15
2013 $-1
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.010B $0.034B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.128B 58.69
Hims & Hers Health (HIMS) United States $11.646B 121.00
Doximity (DOCS) United States $11.561B 53.52
Tempus AI (TEM) United States $10.010B 0.00
IRhythm Technologies (IRTC) United States $4.435B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.739B 0.00
Privia Health (PRVA) United States $2.547B 174.08
Enovis (ENOV) United States $1.826B 10.18
Phreesia (PHR) United States $1.642B 0.00
Schrodinger (SDGR) United States $1.551B 0.00
10x Genomics (TXG) United States $1.535B 0.00
Clover Health Investments (CLOV) United States $1.527B 0.00
Azenta (AZTA) United States $1.475B 68.57
Evolent Health (EVH) United States $1.334B 113.60
Omnicell (OMCL) United States $1.291B 22.78
Claritev (CTEV) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.582B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.475B 0.00
Butterfly Network (BFLY) United States $0.450B 0.00
Talkspace (TALK) United States $0.430B 128.50
Outset Medical (OM) United States $0.333B 0.00
TruBridge (TBRG) United States $0.329B 731.00
Health Catalyst (HCAT) United States $0.269B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
Zepp Health (ZEPP) Netherlands $0.139B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
Pulmonx (LUNG) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.091B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00